Skip to content
Screener

Precigen PGEN Price / sales

Price / sales at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
2.4×+0.4×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
4.2×+0.2×
Gilead Sciences logo
Gilead SciencesGILD
5.2×+0.5×
Allogene Therapeutics logo
Allogene TherapeuticsALLO
20,300.1×+14,614×
Regenxbio logo
RegenxbioRGNX
3.5×+0.8×
Opko Health logo
Opko HealthOPK
1.9×+0.4×

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.47B+358%
Enterprise value$2.56B+382%

Profitability

See full
Gross margin83.6%—
Operating margin-2,890.9%—
Net margin-3,656%—
FCF margin-1,756.5%—

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×—
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

market cap/total revenue=102.3×

Based on the most recent quarter.

The source filing: Precigen’s 10-Q, filed May 13, 2026. Open the filing →

Filed
May 13, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001356090-26-000017

FAQ

What is Precigen's price / sales?
Precigen (PGEN) reported price / sales of 102.3× in Q1 2025.
What is the long-term trend for Precigen's price / sales?
Over 3 years (2020 to 2024), Precigen's price / sales has grown at a 63.5% compound annual growth rate (CAGR), from 19.1× to 83.6×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Ask your AI about Precigen's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude